Enter your login e-mail to the account
Search
- Nová perorální antidiabetika
 doc. MUDr. Tomáš Sechser, CSc.
 (1/2004, clearly )
- Adherence and how to influence it
 doc. MUDr. Michal Vrablík, Ph.D.
 (2/2014, Review articles )
- Overview of results in selected in pharmacoeconomic study of ACEi ramipril
 PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
 (2/2009, Pharmacoeconomics )
- HISTÓRIA FARMAKOEKONOMIKY A ZÁKLADNÁ DEFINÍCIA
 doc. PhDr. Róbert Babeľa, PhD., PharmDr. Tomáš Tesař, PhD., MBA, prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská
 (1/2008, Pharmacoeconomics )
- EPIDEMIOLOGICAL ASPECTS OF HEART FAILURE: EPIDEMY IN PROGRESS. WHAT IS THE REALITY IN OUR CONDITIONS?
 prof. MUDr. Andrej Dukát, CSc., FESC, , MUDr. Anna Baráková
 (9/2006, Main topic )
- Artériová hypertenzia rezistentná na liečbu
 MUDr. Viera Smetanová, PhD.
 (S1/2011, Supplement )
- IT IS POSSIBLE TO AWAIT FROM „DISEASE MANAGEMENT PROGRAM“ PROFESSIONAL, ECONOMICAL PROFITABLY CARE OF DIABETICS 2. TYPE?
 doc. MUDr. Boris Krahulec, CSc., Dr. med. Valerien Sulik
 (10/2007, Spectrum )
- Overview of results in selected pharmacoeconomic study of betablocker bisoprolol
 PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
 (5/2009, Pharmacoeconomics )
- IMPORTANCE OF PHARMACOECONOMICS IN DECISION-MAKING OF PRIMARY CARE PHYSICIANS
 doc. PhDr. Róbert Babeľa, PhD., PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon
 (12/2008, Pharmacoeconomics )
- Memantine – a noncholinergic alternative of treatment for Alzheimer’s and vascular dementia 
 prof. MUDr. Jaromír Švestka, DrSc.
 (3/2004, Psychopharmacology )
- COMPARISON OF THE COST OF TREATMENT OF MAJOR DEPRESSIVE EPIZODE WITH ESCITALOPRAM AND A GENERIC CITALOPRAM BY MEANS OF A PHARMACOECONOMIC MODEL
 doc. MUDr. Václav Filip, CSc., prof. RNDr. Jaromír Antoch, DrSc., MUDr. Jaroslava Skopová
 (3/2005, Review articles )
- Pharmacoeconomy, patients and psychiatrists
 MUDr. Jaroslav Vaněk, MUDr. PhDr. David Vaněk
 (1/2001, Review articles )
- Socioekonomické aspekty migrény
 MUDr. Petr Dočekal
 (2/2003, Main topic )
- INFLUENZA, ITS’ VARIETY, PROPHYLAXIS
 MUDr. Martina Havlíčková, CSc.
 (5/2008, Review articles )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
 prof. MUDr. Jozef Holomáň, CSc.
 (1/2008, Review articles )
- PHARMACOECONOMICAL EVALUATION OF ONCOLOGY DRUGS – DIFFICULTIES AND POSSIBLE SOLUTIONS
 doc. MUDr. Ján Bielik, CSc., PharmDr. Dominikk Tomek, MPH
 (1/2008, Review articles )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
 prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
 (1/2008, Review articles )
- PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
 MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
 (1/2008, Review articles )
- Expected effect of vaccination using bivalent vaccine on incidence of cervical dysplasia and cervical cancer in terms of health care system in Slovak Republic
 doc. MUDr. Ján Bielik, CSc., MUDr. Ladislav Masák, CSc., MUDr. Elena Marušáková, MBA
 (5/2011, Review articles )
- Pharmacoeconomics and ethics in oncology: ethical dilemmas and possible solutions
 Prof. MUDr. Jozef Glasa, CSc., PhD., MUDr. Helena Glasová, PhD.
 (1/2014, Main topic )
- Compliance with topical therapy of skin diseases
 MUDr. Dušan Buchvald, PhD.
 (2/2010, Review articles )
 
				













